![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|33|1|15-17
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.33, Iss.1, 2010-01, pp. : 15-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Erstlinientherapie des metastasierten Nierenzellkarzinoms (mRCC) – Update 2009
Oncology Research and Treatment, Vol. 33, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Die urologische Therapie des Nierenzellkarzinoms
Wiener Medizinische Wochenschrift, Vol. 158, Iss. 11-12, 2008-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Systemtherapie des metastasierten malignen Melanoms
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 12, 2015-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ausblick: Therapie des Nierenzellkarzinoms von morgen
Oncology Research and Treatment, Vol. 33, Iss. 1, 2010-01 ,pp. :